Literature DB >> 1369403

Adeno-associated virus vectors.

B J Carter1.   

Abstract

Adeno-associated virus is a human parvovirus that integrates its DNA genome into host cell chromosomes with very high efficiency. This suggests that adeno-associated virus may be a useful vector for human gene therapy. Interest in adeno-associated virus vectors increased greatly in the last year following reports that adeno-associated virus genome integration may be site specific and occur at preferred sites in the human genome. Several genes relevant to the treatment of genetic or infectious diseases have been expressed in adeno-associated virus vectors in vitro.

Entities:  

Mesh:

Year:  1992        PMID: 1369403     DOI: 10.1016/0958-1669(92)90082-t

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  24 in total

1.  Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.

Authors:  Z Yan; Y Zhang; D Duan; J F Engelhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein.

Authors:  M Grifman; N N Chen; G P Gao; T Cathomen; J M Wilson; M D Weitzman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Reproducible transfection in the presence of carrier DNA using FuGENE6 and Lipofectamine2000.

Authors:  Takao Susa; Takako Kato; Yukio Kato
Journal:  Mol Biol Rep       Date:  2007-05-17       Impact factor: 2.316

Review 4.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

5.  Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.

Authors:  K A Vincent; S T Piraino; S C Wadsworth
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 6.  Gene therapy in pediatric oncology.

Authors:  E Benaim; B P Sorrentino
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

7.  Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers.

Authors:  M D Weitzman; K J Fisher; J M Wilson
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 8.  Gene therapy vectors as drug delivery systems.

Authors:  S A Afione; C K Conrad; T R Flotte
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

9.  Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome.

Authors:  C Giraud; E Winocour; K I Berns
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

Authors:  T R Flotte; S A Afione; C Conrad; S A McGrath; R Solow; H Oka; P L Zeitlin; W B Guggino; B J Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.